StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Trading Down 0.3 %
Shares of Brooklyn ImmunoTherapeutics stock opened at $7.37 on Wednesday. Brooklyn ImmunoTherapeutics has a 12-month low of $6.66 and a 12-month high of $8.31. The stock has a market cap of $433.55 million, a PE ratio of -3.25 and a beta of 4.61. The company has a 50-day moving average of $1.07 and a two-hundred day moving average of $1.08.
About Brooklyn ImmunoTherapeutics
Read More
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Investing in the High PE Growth Stocks
- Buffett’s on the Sidelines – Should You Follow?
- 3 Ways To Invest In Coffee, Other Than Drinking It
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Want to Profit on the Downtrend? Downtrends, Explained.
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.